Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002943356 | SCV003275204 | uncertain significance | not provided | 2023-09-08 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 3383 of the FAT2 protein (p.Ala3383Val). This variant is present in population databases (rs150088361, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with FAT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2064288). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FAT2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004068011 | SCV003758377 | uncertain significance | not specified | 2022-04-08 | criteria provided, single submitter | clinical testing | The c.10148C>T (p.A3383V) alteration is located in exon 15 (coding exon 15) of the FAT2 gene. This alteration results from a C to T substitution at nucleotide position 10148, causing the alanine (A) at amino acid position 3383 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV002943356 | SCV004157444 | benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | FAT2: BS1, BS2 |
Prevention |
RCV003943631 | SCV004762810 | likely benign | FAT2-related disorder | 2022-06-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |